Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Circulating Tumor Cells is a collective term for all types of tumor cells present in the peripheral blood.CTC assays monitor trends in CTC type and number by capturing and detecting CTCs present in the peripheral blood to monitor tumor dynamics, assess treatment efficacy, and enable real-time individual therapy.
The many potential applications of Circulating Tumor Cells in prediagnosis, pretreatment, and during and after treatment offer lucrative growth opportunities for participants involved in the development of Circulating Tumor Cells enrichment and isolation products. The global circulating tumor cells market is expected to reach USD 9.6 billion by 2025. The continued growth of the Circulating Tumor Cells market in North America can be attributed to the presence of active players such as Advanced Cell Diagnostics. These market players are adopting various strategies to enhance their market share. For instance, in November 2019, Biocept, Inc. initiated the Target Selector pan-TRK assay to identify TRK proteins. The assay, based on the company's circulating tumor cell platform, detects TRK gene alterations in blood samples. These initiatives have increased the availability of cost-effective, non-invasive biomarker assays for cancer detection in the country. Moreover, high population susceptibility to cancer, increasing market penetration, and technologically advanced cancer care infrastructure are some of the key factors accounting for its huge share. On the other hand, Asia Pacific is expected to grow at a considerable rate owing to the highly unmet diagnostic needs and rapidly growing patient awareness regarding early detection and risk assessment of cancer.
Growing demand for effective diagnostic and screening tests and technological advancements in cancer detection is expected to drive the growth of the Circulating Tumor Cells market. The high adoption of concomitant diagnostics for monitoring the tumor characteristics of cytotoxic drugs for elimination is one of the factors driving the Circulating Tumor Cells market demand. Key stakeholders have been working on the development of circulating tumor cell based tests that may help in cancer diagnosis. The growing development of microarray technology is another key factor driving the growth of the circulating tumor cells market.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Circulating Tumor Cells (CTC) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Circulating Tumor Cells (CTC) market. Detailed analysis of key players, along with key growth strategies adopted by Circulating Tumor Cells (CTC) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Agilent Technologies, Inc
Thermo Fisher Scientific, Inc
Toshiba Corporation
Bio-Rad Laboratories, Inc
Koninklijke Philips NV
General Electric
Illumina, Inc
FHoffmann-La Roche Ltd
Abbott
Siemens Healthcare GmbH
By Type:
CTC Detection & Enrichment Methods
CTC Direct Detection Methods
CTC Analysis
By End-User:
Clinical/Liquid Biopsy
Research
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Circulating Tumor Cells (CTC) Market
-
1.3 Market Segment by Type
-
1.3.1 USA Circulating Tumor Cells (CTC) Market Size and Growth Rate of CTC Detection & Enrichment Methods from 2016 to 2027
-
1.3.2 USA Circulating Tumor Cells (CTC) Market Size and Growth Rate of CTC Direct Detection Methods from 2016 to 2027
-
1.3.3 USA Circulating Tumor Cells (CTC) Market Size and Growth Rate of CTC Analysis from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Circulating Tumor Cells (CTC) Market Size and Growth Rate of Clinical/Liquid Biopsy from 2016 to 2027
-
1.4.2 USA Circulating Tumor Cells (CTC) Market Size and Growth Rate of Research from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Circulating Tumor Cells (CTC) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Circulating Tumor Cells (CTC) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Circulating Tumor Cells (CTC) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Circulating Tumor Cells (CTC) Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Circulating Tumor Cells (CTC) Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Circulating Tumor Cells (CTC) by Major Types
-
3.4.1 Market Size and Growth Rate of CTC Detection & Enrichment Methods
-
3.4.2 Market Size and Growth Rate of CTC Direct Detection Methods
-
3.4.3 Market Size and Growth Rate of CTC Analysis
4 Segmentation of Circulating Tumor Cells (CTC) Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Circulating Tumor Cells (CTC) by Major End-Users
-
4.4.1 Market Size and Growth Rate of Circulating Tumor Cells (CTC) in Clinical/Liquid Biopsy
-
4.4.2 Market Size and Growth Rate of Circulating Tumor Cells (CTC) in Research
5 Market Analysis by Regions
-
5.1 USA Circulating Tumor Cells (CTC) Production Analysis by Regions
-
5.2 USA Circulating Tumor Cells (CTC) Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Circulating Tumor Cells (CTC) Landscape Analysis
-
6.1 West USA Circulating Tumor Cells (CTC) Landscape Analysis by Major Types
-
6.2 West USA Circulating Tumor Cells (CTC) Landscape Analysis by Major End-Users
7 South USA Circulating Tumor Cells (CTC) Landscape Analysis
-
7.1 South USA Circulating Tumor Cells (CTC) Landscape Analysis by Major Types
-
7.2 South USA Circulating Tumor Cells (CTC) Landscape Analysis by Major End-Users
8 Middle West USA Circulating Tumor Cells (CTC) Landscape Analysis
-
8.1 Middle West USA Circulating Tumor Cells (CTC) Landscape Analysis by Major Types
-
8.2 Middle West USA Circulating Tumor Cells (CTC) Landscape Analysis by Major End-Users
9 Northeast USA Circulating Tumor Cells (CTC) Landscape Analysis
-
9.1 Northeast USA Circulating Tumor Cells (CTC) Landscape Analysis by Major Types
-
9.2 Northeast USA Circulating Tumor Cells (CTC) Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Agilent Technologies, Inc
-
10.1.1 Agilent Technologies, Inc Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Thermo Fisher Scientific, Inc
-
10.2.1 Thermo Fisher Scientific, Inc Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Toshiba Corporation
-
10.3.1 Toshiba Corporation Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Bio-Rad Laboratories, Inc
-
10.4.1 Bio-Rad Laboratories, Inc Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Koninklijke Philips NV
-
10.5.1 Koninklijke Philips NV Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 General Electric
-
10.6.1 General Electric Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Illumina, Inc
-
10.7.1 Illumina, Inc Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 FHoffmann-La Roche Ltd
-
10.8.1 FHoffmann-La Roche Ltd Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Abbott
-
10.9.1 Abbott Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Siemens Healthcare GmbH
-
10.10.1 Siemens Healthcare GmbH Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Circulating Tumor Cells (CTC) Market Size and Growth Rate of CTC Detection & Enrichment Methods from 2016 to 2027
-
Figure USA Circulating Tumor Cells (CTC) Market Size and Growth Rate of CTC Direct Detection Methods from 2016 to 2027
-
Figure USA Circulating Tumor Cells (CTC) Market Size and Growth Rate of CTC Analysis from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Circulating Tumor Cells (CTC) Market Size and Growth Rate of Clinical/Liquid Biopsy from 2016 to 2027
-
Figure USA Circulating Tumor Cells (CTC) Market Size and Growth Rate of Research from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Circulating Tumor Cells (CTC) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Circulating Tumor Cells (CTC) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Circulating Tumor Cells (CTC) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Circulating Tumor Cells (CTC) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Circulating Tumor Cells (CTC) Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Circulating Tumor Cells (CTC)
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Circulating Tumor Cells (CTC) by Different Types from 2016 to 2027
-
Table Consumption Share of Circulating Tumor Cells (CTC) by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of CTC Detection & Enrichment Methods
-
Figure Market Size and Growth Rate of CTC Direct Detection Methods
-
Figure Market Size and Growth Rate of CTC Analysis
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Circulating Tumor Cells (CTC) by Different End-Users from 2016 to 2027
-
Table Consumption Share of Circulating Tumor Cells (CTC) by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Clinical/Liquid Biopsy
-
Figure Market Size and Growth Rate of Research
-
Table USA Circulating Tumor Cells (CTC) Production by Regions
-
Table USA Circulating Tumor Cells (CTC) Production Share by Regions
-
Figure USA Circulating Tumor Cells (CTC) Production Share by Regions in 2016
-
Figure USA Circulating Tumor Cells (CTC) Production Share by Regions in 2021
-
Figure USA Circulating Tumor Cells (CTC) Production Share by Regions in 2027
-
Table USA Circulating Tumor Cells (CTC) Consumption by Regions
-
Table USA Circulating Tumor Cells (CTC) Consumption Share by Regions
-
Figure USA Circulating Tumor Cells (CTC) Consumption Share by Regions in 2016
-
Figure USA Circulating Tumor Cells (CTC) Consumption Share by Regions in 2021
-
Figure USA Circulating Tumor Cells (CTC) Consumption Share by Regions in 2027
-
Table West USA Circulating Tumor Cells (CTC) Consumption by Types from 2016 to 2027
-
Table West USA Circulating Tumor Cells (CTC) Consumption Share by Types from 2016 to 2027
-
Figure West USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2016
-
Figure West USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2021
-
Figure West USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2027
-
Table West USA Circulating Tumor Cells (CTC) Consumption by End-Users from 2016 to 2027
-
Table West USA Circulating Tumor Cells (CTC) Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2016
-
Figure West USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2021
-
Figure West USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2027
-
Table South USA Circulating Tumor Cells (CTC) Consumption by Types from 2016 to 2027
-
Table South USA Circulating Tumor Cells (CTC) Consumption Share by Types from 2016 to 2027
-
Figure South USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2016
-
Figure South USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2021
-
Figure South USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2027
-
Table South USA Circulating Tumor Cells (CTC) Consumption by End-Users from 2016 to 2027
-
Table South USA Circulating Tumor Cells (CTC) Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2016
-
Figure South USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2021
-
Figure South USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2027
-
Table Middle West USA Circulating Tumor Cells (CTC) Consumption by Types from 2016 to 2027
-
Table Middle West USA Circulating Tumor Cells (CTC) Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2016
-
Figure Middle West USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2021
-
Figure Middle West USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2027
-
Table Middle West USA Circulating Tumor Cells (CTC) Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Circulating Tumor Cells (CTC) Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2016
-
Figure Middle West USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2021
-
Figure Middle West USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2027
-
Table Northeast USA Circulating Tumor Cells (CTC) Consumption by Types from 2016 to 2027
-
Table Northeast USA Circulating Tumor Cells (CTC) Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2016
-
Figure Northeast USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2021
-
Figure Northeast USA Circulating Tumor Cells (CTC) Consumption Share by Types in 2027
-
Table Northeast USA Circulating Tumor Cells (CTC) Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Circulating Tumor Cells (CTC) Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2016
-
Figure Northeast USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2021
-
Figure Northeast USA Circulating Tumor Cells (CTC) Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Agilent Technologies, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies, Inc
-
Figure Sales and Growth Rate Analysis of Agilent Technologies, Inc
-
Figure Revenue and Market Share Analysis of Agilent Technologies, Inc
-
Table Product and Service Introduction of Agilent Technologies, Inc
-
Table Company Profile and Development Status of Thermo Fisher Scientific, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific, Inc
-
Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific, Inc
-
Figure Revenue and Market Share Analysis of Thermo Fisher Scientific, Inc
-
Table Product and Service Introduction of Thermo Fisher Scientific, Inc
-
Table Company Profile and Development Status of Toshiba Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Toshiba Corporation
-
Figure Sales and Growth Rate Analysis of Toshiba Corporation
-
Figure Revenue and Market Share Analysis of Toshiba Corporation
-
Table Product and Service Introduction of Toshiba Corporation
-
Table Company Profile and Development Status of Bio-Rad Laboratories, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Rad Laboratories, Inc
-
Figure Sales and Growth Rate Analysis of Bio-Rad Laboratories, Inc
-
Figure Revenue and Market Share Analysis of Bio-Rad Laboratories, Inc
-
Table Product and Service Introduction of Bio-Rad Laboratories, Inc
-
Table Company Profile and Development Status of Koninklijke Philips NV
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Koninklijke Philips NV
-
Figure Sales and Growth Rate Analysis of Koninklijke Philips NV
-
Figure Revenue and Market Share Analysis of Koninklijke Philips NV
-
Table Product and Service Introduction of Koninklijke Philips NV
-
Table Company Profile and Development Status of General Electric
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of General Electric
-
Figure Sales and Growth Rate Analysis of General Electric
-
Figure Revenue and Market Share Analysis of General Electric
-
Table Product and Service Introduction of General Electric
-
Table Company Profile and Development Status of Illumina, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina, Inc
-
Figure Sales and Growth Rate Analysis of Illumina, Inc
-
Figure Revenue and Market Share Analysis of Illumina, Inc
-
Table Product and Service Introduction of Illumina, Inc
-
Table Company Profile and Development Status of FHoffmann-La Roche Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of FHoffmann-La Roche Ltd
-
Figure Sales and Growth Rate Analysis of FHoffmann-La Roche Ltd
-
Figure Revenue and Market Share Analysis of FHoffmann-La Roche Ltd
-
Table Product and Service Introduction of FHoffmann-La Roche Ltd
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of Siemens Healthcare GmbH
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare GmbH
-
Figure Sales and Growth Rate Analysis of Siemens Healthcare GmbH
-
Figure Revenue and Market Share Analysis of Siemens Healthcare GmbH
-
Table Product and Service Introduction of Siemens Healthcare GmbH
-
